全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Role of P-Gp in Treatment of Cancer

DOI: 10.4236/jct.2025.161001, PP. 1-17

Keywords: P-Glycoprotein (P-Gp), Multi-Drug Resistance (MDR), Cancer Treatment, ABC Transporters, Chemotherapy Resistance, P-Gp Inhibitors, Drug Efflux Mechanisms Fourth-Generation Inhibitors

Full-Text   Cite this paper   Add to My Lib

Abstract:

P-glycoprotein (P-gp), a member of the ATP-binding cassette (ABC) family of transporters, plays a crucial role in the development of multi-drug resistance (MDR) in cancer treatment. P-gp actively pumps chemotherapeutic drugs out of cancer cells, reducing their intracellular concentrations and thereby diminishing their efficacy. This review explores the mechanisms by which P-gp contributes to MDR, including intrinsic and acquired resistance. It also discusses various strategies to inhibit P-gp, such as blocking drug binding sites, interfering with ATP hydrolysis, and altering cell membrane integrity. The potential of fourth-generation P-gp inhibitors and other novel approaches to enhance the effectiveness of cancer therapies is also examined. Understanding and overcoming P-gp-mediated MDR is essential for improving therapeutic outcomes in cancer patients.

References

[1]  Brown, J.S., Amend, S.R., Austin, R.H., Gatenby, R.A., Hammarlund, E.U. and Pienta, K.J. (2023) Updating the Definition of Cancer. Molecular Cancer Research, 21, 1142-1147.
https://doi.org/10.1158/1541-7786.mcr-23-0411

[2]  Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660

[3]  Soerjomataram, I. and Bray, F. (2021) Planning for Tomorrow: Global Cancer Incidence and the Role of Prevention 2020-2070. Nature Reviews Clinical Oncology, 18, 663-672.
https://doi.org/10.1038/s41571-021-00514-z

[4]  Fitzgerald, R.C., Antoniou, A.C., Fruk, L. and Rosenfeld, N. (2022) The Future of Early Cancer Detection. Nature Medicine, 28, 666-677.
https://doi.org/10.1038/s41591-022-01746-x

[5]  Crosby, D., Bhatia, S., Brindle, K.M., Coussens, L.M., Dive, C., Emberton, M., et al. (2022) Early Detection of Cancer. Science, 375, eaay9040.
https://doi.org/10.1126/science.aay9040
[6]  Duan, C., Yu, M., Xu, J., Li, B., Zhao, Y. and Kankala, R.K. (2023) Overcoming Cancer Multi-Drug Resistance (MDR): Reasons, Mechanisms, Nanotherapeutic Solutions, and Challenges. Biomedicine & Pharmacotherapy, 162, Article ID: 114643.
https://doi.org/10.1016/j.biopha.2023.114643

[7]  Wiese, M. and Pajeva, I. (2001) Structure-activity Relationships of Multidrug Resistance Reversers. Current Medicinal Chemistry, 8, 685-713.
https://doi.org/10.2174/0929867013373138

[8]  Ramos, A., Sadeghi, S. and Tabatabaeian, H. (2021) Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them. International Journal of Molecular Sciences, 22, Article No. 9451.
https://doi.org/10.3390/ijms22179451

[9]  Wang, J., Wu, Z., Yang, Y., Teng, Q., Li, Y., Lei, Z., et al. (2021) ATP‐Binding Cassette (ABC) Transporters in Cancer: A Review of Recent Updates. Journal of Evidence-Based Medicine, 14, 232-256.
https://doi.org/10.1111/jebm.12434

[10]  Karthika, C., Sureshkumar, R., Zehravi, M., Akter, R., Ali, F., Ramproshad, S., et al. (2022) Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein. Life, 12, Article No. 897.
https://doi.org/10.3390/life12060897

[11]  Al-Thubiani, W.S. (2023) The Role of P-Glycoprotein (p-Gp) in Cancer Multidrug Resistance (MDR): Challenges for Inhibiting P-Gp in the Context of Overcoming MDR. Journal of Pharmaceutical Research International, 35, 44-58.
https://doi.org/10.9734/jpri/2023/v35i237422

[12]  Czornyj, L., Auzmendi, J. and Lazarowski, A. (2023) Transporter Hypothesis in Pharmacoresistant Epilepsies: Is It at the Central or Peripheral Level? In: Rocha, L.L., Lazarowski, A. and Cavalheiro, E.A., Eds., Pharmacoresistance in Epilepsy: From Genes and Molecules to Promising Therapies, Springer International Publishing, 85-107.
https://doi.org/10.1007/978-3-031-36526-3_6

[13]  Chai, S., To, K.K. and Lin, G. (2010) Circumvention of Multi-Drug Resistance of Cancer Cells by Chinese Herbal Medicines. Chinese Medicine, 5, Article No. 26.
https://doi.org/10.1186/1749-8546-5-26

[14]  Cai, M., Song, X., Li, X., Chen, M., Guo, J., Yang, D., et al. (2023) Current Therapy and Drug Resistance in Metastatic Castration-Resistant Prostate Cancer. Drug Resistance Updates, 68, Article ID: 100962.
https://doi.org/10.1016/j.drup.2023.100962

[15]  Sears, J.E. and Boger, D.L. (2015) Total Synthesis of Vinblastine, Related Natural Products, and Key Analogues and Development of Inspired Methodology Suitable for the Systematic Study of Their Structure-function Properties. Accounts of Chemical Research, 48, 653-662.
https://doi.org/10.1021/ar500400w

[16]  Huang, J. and Ecker, G.F. (2023) A Structure-Based View on Abc-Transporter Linked to Multidrug Resistance. Molecules, 28, Article No. 495.
https://doi.org/10.3390/molecules28020495
[17]  Emmert, D., Campos, C.R., Ward, D., Lu, P., Namanja, H.A., Bohn, K., et al. (2014) Reversible Dimers of the Atypical Antipsychotic Quetiapine Inhibit P-Glycoprotein-Mediated Efflux in Vitro with Increased Binding Affinity and in Situ at the Blood-Brain Barrier. ACS Chemical Neuroscience, 5, 305-317.
https://doi.org/10.1021/cn4002329

[18]  Tian, Y., Lei, Y., Wang, Y., Lai, J., Wang, J. and Xia, F. (2023) Mechanism of Multidrug Resistance to Chemotherapy Mediated by P-Glycoprotein (Review). International Journal of Oncology, 63, Article No. 119.
https://doi.org/10.3892/ijo.2023.5567
[19]  Attia, M.S., Elsebaey, M.T., Yahya, G., Chopra, H., Marzouk, M.A., Yahya, A., et al. (2023) Pharmaceutical Polymers and P-Glycoprotein: Current Trends and Possible Outcomes in Drug Delivery. Materials Today Communications, 34, Article ID: 105318.
https://doi.org/10.1016/j.mtcomm.2023.105318

[20]  Aashish, Muheem, A., Nehal, N., Sartaj, A., Baboota, S. and Ali, J. (2023) Importance of P-Gp Inhibitors and Nanoengineered Approaches for Effective Delivery of Anti-Retroviral Drugs across Barriers in HIV Management. Journal of Drug Delivery Science and Technology, 87, Article ID: 104791.
https://doi.org/10.1016/j.jddst.2023.104791

[21]  Pop, I., Pop, L., Vitetta, E. and Ghetie, M. (2008) Generation of Multidrug Resistant Lymphoma Cell Lines Stably Expressing P-Glycoprotein. Oncology Reports, 19, 889-895.
https://doi.org/10.3892/or.19.4.889

[22]  Guo, Y., Ashrafizadeh, M., Tambuwala, M.M., Ren, J., Orive, G. and Yu, G. (2024) P-glycoprotein (p-Gp)-Driven Cancer Drug Resistance: Biological Profile, Non-Coding RNAs, Drugs and Nanomodulators. Drug Discovery Today, 29, Article ID: 104161.
https://doi.org/10.1016/j.drudis.2024.104161

[23]  Shen, Y. and Yan, Z. (2021) Systematic Prediction of Drug Resistance Caused by Transporter Genes in Cancer Cells. Scientific Reports, 11, Article No. 7400.
https://doi.org/10.1038/s41598-021-86921-9

[24]  Liu, B., Yu, X., Liu, L., Wang, L., Wang, J., Huang, Q., et al. (2023) Modular Biomimetic Strategy Enabled Discovery of Simplified Pseudo-Natural Macrocyclic P-Glycoprotein Inhibitors Capable of Overcoming Multidrug Resistance. Journal of Medicinal Chemistry, 66, 2550-2565.
https://doi.org/10.1021/acs.jmedchem.2c01424

[25]  Goel, N., Hashmi, Z., Khan, N., Ahmad, R. and Khan, W.H. (2023) Recent Strategies to Combat Multidrug Resistance. In: Wani, M.Y. and Ahmad, A., Eds., Non-Traditional Approaches to Combat Antimicrobial Drug Resistance, Springer Nature, 1-27.
https://doi.org/10.1007/978-981-19-9167-7_1

[26]  Ahmad, A., Akhtar, J., Ahmad, M., Badruddeen, Khan, M.I., Singh, A., et al. (2024) Bedaquiline Delivery Innovations: A Review on Advancing MDR-TB Treatment Strategies. Recent Advances in Anti-Infective Drug Discovery, 20, 1-18.
https://doi.org/10.2174/0127724344318310241018113206

[27]  Ravichandran, S.K., Keerthanah, S.M.T., Swarna, S. and Gopinath, R. (2024) Innovative Approaches in Combating Antimicrobial Resistance: A Comprehensive Review. International Journal of Pharmaceutical and Clinical Research, 16, 245-254.
[28]  Safaei, M., Khalighi, F., Behabadi, F.A., Abpeikar, Z., Goodarzi, A., Kouhpayeh, S.A., et al. (2023) Liposomal Nanocarriers Containing siRNA as Small Molecule-Based Drugs to Overcome Cancer Drug Resistance. Nanomedicine, 18, 1745-1768.
https://doi.org/10.2217/nnm-2023-0176

[29]  Li, C., Sun, B. Q. and Gai, X. D. (2014). Compounds from Chinese Herbal Medicines as Reversal Agents for P-Glycoprotein-Mediated Multidrug Resistance in Tumours. Clinical and Translational Oncology, 16, 593-598.
[30]  Dey, S., Ramachandra, M., Pastan, I., Gottesman, M.M. and Ambudkar, S.V. (1997) Evidence for Two Nonidentical Drug-Interaction Sites in the Human P-Glycoprotein. Proceedings of the National Academy of Sciences, 94, 10594-10599.
https://doi.org/10.1073/pnas.94.20.10594

[31]  Wang, L., Wang, X., Zhu, X., Zhong, L., Jiang, Q., Wang, Y., et al. (2024) Drug Resistance in Ovarian Cancer: From Mechanism to Clinical Trial. Molecular Cancer, 23, Article No. 66.
https://doi.org/10.1186/s12943-024-01967-3

[32]  Kaveh Zenjanab, M., Alimohammadvand, S., Doustmihan, A., Kianian, S., Sadeghzadeh Oskouei, B., Mazloomi, M., et al. (2024) Paclitaxel for Breast Cancer Therapy: A Review on Effective Drug Combination Modalities and Nano Drug Delivery Platforms. Journal of Drug Delivery Science and Technology, 95, Article ID: 105567.
https://doi.org/10.1016/j.jddst.2024.105567

[33]  Sosnik, A. (2013) Reversal of Multidrug Resistance by the Inhibition of ATP-Binding Cassette Pumps Employing “Generally Recognized as Safe” (GRAS) Nanopharmaceuticals: A Review. Advanced Drug Delivery Reviews, 65, 1828-1851.
https://doi.org/10.1016/j.addr.2013.09.002

[34]  Daniel, D., Frengki, F., Jalaluddin, M., Sari, W.E., Rosmaidar, R., Hasriati, H., et al. (2024) Multi-Drug Resistance-1 (MDR-1) Gene Expression in MCF-7 Cells after Treated with Doxorubicin-Deoxyelephantopin Combination and Prediction of Inhibitory Activity against Pgp Receptors with in Silico. Jurnal Natural, 24, 140-145.
https://doi.org/10.24815/jn.v24i3.33237

[35]  Henrique, R., Oliveira, A.I., Costa, V.L., Baptista, T., Martins, A.T., Morais, A., et al. (2013) Epigenetic Regulation of MDR1 Gene through Post-Translational Histone Modifications in Prostate Cancer. BMC Genomics, 14, Article No. 898.
https://doi.org/10.1186/1471-2164-14-898

[36]  Varma, M. (2003) P-Glycoprotein Inhibitors and Their Screening: A Perspective from Bioavailability Enhancement. Pharmacological Research, 48, 347-359.
https://doi.org/10.1016/s1043-6618(03)00158-0

[37]  Fortuna, A., Alves, G. and Falcão, A. (2011) In Vitro and in Vivo Relevance of the P-Glycoprotein Probe Substrates in Drug Discovery and Development: Focus on Rhodamine 123, Digoxin and Talinolol. Journal of Bioequivalence & Bioavailability, 1, 1-23.
https://doi.org/10.4172/jbb.s2-001

[38]  van Asperen, J., van Tellingen, O., Sparreboom, A., Schinkel, A., Borst, P., Nooijen, W., et al. (1997) Enhanced Oral Bioavailability of Paclitaxel in Mice Treated with the P-Glycoprotein Blocker SDZ PSC 833. British Journal of Cancer, 76, 1181-1183.
https://doi.org/10.1038/bjc.1997.530

[39]  Amin, M.L. (2013) P-Glycoprotein Inhibition for Optimal Drug Delivery. Drug Target Insights, 7, 27-34.
https://doi.org/10.4137/dti.s12519

[40]  Liu, L.L., Liu, Y.E. and Fang, G.T. (2008) Reversal Effect of Panax Notoginseng Saponins on Multidrug Resistance Breast Cancer Cell MCF/ADM. Lishizhen Medicine and Materia Medica Research, 19, 954-956.
[41]  Johnson, Z.L. and Chen, J. (2017) Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1. Cell, 168, 1075-1085.e9.
https://doi.org/10.1016/j.cell.2017.01.041

[42]  Clay, A.T. and Sharom, F.J. (2014) Multidrug Resistance Protein: P-Glycoprotein. In: You, G.F. and Morris, M.E., Eds., Drug Transporters: Molecular Characterization and Role in Drug Disposition, 2nd Edition, John Wiley & Sons, Inc., 141-160.
https://doi.org/10.1002/9781118705308.ch9

[43]  Kang, M.J., Cho, J.Y., Shim, B.H., Kim, D.K. and Lee, J. (2009) Bioavailability Enhancing Activities of Natural Compounds from Medicinal Plants. Journal of Medicinal Plants Research, 3, 1204-1211.
[44]  Farha, M.A. and Brown, E.D. (2016) Strategies for Target Identification of Antimicrobial Natural Products. Natural Product Reports, 33, 668-680.
https://doi.org/10.1039/c5np00127g

[45]  Dewanjee, S., Dua, T., Bhattacharjee, N., Das, A., Gangopadhyay, M., Khanra, R., et al. (2017) Natural Products as Alternative Choices for P-Glycoprotein (p-Gp) Inhibition. Molecules, 22, Article No. 871.
https://doi.org/10.3390/molecules22060871

[46]  Marzorati, S., Verotta, L. and Trasatti, S.P. (2018) Green Corrosion Inhibitors from Natural Sources and Biomass Wastes. Molecules, 24, Article No. 48.
https://doi.org/10.3390/molecules24010048

[47]  Roemer, T., Xu, D., Singh, S.B., Parish, C.A., Harris, G., Wang, H., et al. (2011) Confronting the Challenges of Natural Product-Based Antifungal Discovery. Chemistry & Biology, 18, 148-164.
https://doi.org/10.1016/j.chembiol.2011.01.009

[48]  Sarker, S.D., Latif, Z. and Gray, A.I. (2006) An Introduction to Natural Products Isolation. In: Sarker, S.D., Latif, Z. and Gray, A.I., Eds., Natural Products Isolation, Humana Press, 1-25.
https://doi.org/10.1385/1-59259-955-9:1

[49]  Skalli, S., Zaid, A. and Soulaymani, R. (2007) Drug Interactions with Herbal Medicines. Therapeutic Drug Monitoring, 29, 679-686.
https://doi.org/10.1097/ftd.0b013e31815c17f6

[50]  Cragg, G.M., Grothaus, P.G. and Newman, D.J. (2009) Impact of Natural Products on Developing New Anti-Cancer Agents. Chemical Reviews, 109, 3012-3043.
https://doi.org/10.1021/cr900019j

[51]  Li, J., Jaimes, K.F. and Aller, S.G. (2013) Refined Structures of Mouse P‐Glycoprotein. Protein Science, 23, 34-46.
https://doi.org/10.1002/pro.2387

[52]  Robinson, K. and Tiriveedhi, V. (2020) Perplexing Role of P-Glycoprotein in Tumor Microenvironment. Frontiers in Oncology, 10, Article No. 265.
https://doi.org/10.3389/fonc.2020.00265

[53]  Banerjee, S. and Kaushik, S. (2016) Role of P-Glycoprotein and its Inhibition in Cancer Therapy: A Review. International Journal of Pharma and Bio Sciences, 207, 207-219.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133